Il rapporto
Analisi approfondite sul finanziamento aziendale, strategie di crescita e approfondimenti di mercato dalle aziende più innovative del mondo
216 report e oltre
Star Therapeutics Raises $125M in Series C
Star Therapeutics, a Biotech company based in Cambridge, MA, has raised $125M in Series C at a $650M valuation led by RA Capital, Arch Venture Partners.
Star Therapeutics raises $125M Series D
Star Therapeutics raises $125M in Series D. Developing antibody therapies for autoimmune and inflammatory diseases...
Star Therapeutics raises $125M Series B at $600M valuation
Star Therapeutics raises $125M in Series B at $600M valuation. Antibody therapies for cancer...
Star Therapeutics raises $125M Series C at $650M valuation
Star Therapeutics raises $125M in Series C at $650M valuation. Cell therapy platform for cancer treatment...
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Denali Therapeutics raises $217M Series C at $5B valuation
Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Seres Therapeutics raises $113M Series E at $450M valuation
Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Visualizzazione di 9 report • Pagina 1 • Categoria: all
Rimani avanti rispetto al mercato
Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.